DOI QR코드

DOI QR Code

Non-Randomized Confirmatory Trial of Laparoscopy-Assisted Total Gastrectomy and Proximal Gastrectomy with Nodal Dissection for Clinical Stage I Gastric Cancer: Japan Clinical Oncology Group Study JCOG1401

  • Kataoka, Kozo (JCOG Data Center/Operations Office, National Cancer Center) ;
  • Katai, Hitoshi (Gastric Surgery Division, National Cancer Center Hospital) ;
  • Mizusawa, Junki (JCOG Data Center/Operations Office, National Cancer Center) ;
  • Katayama, Hiroshi (JCOG Data Center/Operations Office, National Cancer Center) ;
  • Nakamura, Kenichi (JCOG Data Center/Operations Office, National Cancer Center) ;
  • Morita, Shinji (Gastric Surgery Division, National Cancer Center Hospital) ;
  • Yoshikawa, Takaki (Department of Gastrointestinal Surgery, Kanagawa Cancer Center) ;
  • Ito, Seiji (Department of Gastroenterological Surgery, Aichi Cancer Center Hospital) ;
  • Kinoshita, Takahiro (Gastric Surgery Division, National Cancer Center Hospital East) ;
  • Fukagawa, Takeo (Gastric Surgery Division, National Cancer Center Hospital) ;
  • Sasako, Mitsuru (Department of Surgery, Hyogo College of Medicine)
  • Received : 2016.03.29
  • Accepted : 2016.05.07
  • Published : 2016.06.30

Abstract

Several prospective studies on laparoscopy-assisted distal gastrectomy for early gastric cancer have been initiated, but no prospective study evaluating laparoscopy-assisted total gastrectomy or laparoscopy-assisted proximal gastrectomy has been completed to date. A non-randomized confirmatory trial was commenced in April 2015 to evaluate the safety of laparoscopy-assisted total gastrectomy and laparoscopy-assisted proximal gastrectomy for clinical stage I gastric cancer. A total of 245 patients will be accrued from 42 Japanese institutions over 3 years. The primary endpoint is the proportion of patients with anastomotic leakage. The secondary endpoints are overall survival, relapse-free survival, proportion of patients with completed laparoscopy-assisted total gastrectomy or laparoscopy-assisted proximal gastrectomy, proportion of patients with conversion to open surgery, adverse events, and short-term clinical outcomes. The UMIN Clinical Trials Registry number is UMIN000017155.

Keywords

References

  1. Kakizoe T, Yamaguchi N, Mitsuhashi F. Cancer statistics in Japan: foundation for promotion of cancer research 2000. Tokyo, Japan: Foundation for Promotion of Cancer Research, 2001:36-39.
  2. Kitano S, Iso Y, Moriyama M, Sugimachi K. Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 1994;4:146-148.
  3. Katai H, Sasako M, Fukuda H, Nakamura K, Hiki N, Saka M, et al; JCOG Gastric Cancer Surgical Study Group. Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG 0703). Gastric Cancer 2010;13:238-244. https://doi.org/10.1007/s10120-010-0565-0
  4. Nakamura K, Katai H, Mizusawa J, Yoshikawa T, Ando M, Terashima M, et al. A phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric Cancer (JCOG0912). Jpn J Clin Oncol 2013;43:324-327. https://doi.org/10.1093/jjco/hys220
  5. National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 [Internet]. Bethesda (MD): National Cancer Institute; 2010 [cited 2015 Mar 5]. Available from: http://evs.nci.nih.gov/ftp1/CTCAE/About.html.
  6. Katayama H, Kurokawa Y, Nakamura K, Ito H, Kanemitsu Y, Masuda N, et al. Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today 2016;46:668-685. https://doi.org/10.1007/s00595-015-1236-x
  7. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 2nd English edition. Gastric Cancer 1998;1:10-24. https://doi.org/10.1007/PL00011681
  8. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4, in Japanese). Tokyo: Kanehara & Co., Ltd., 2014.
  9. Deguchi Y, Fukagawa T, Morita S. Identification of risk factors for esophagojejunal anastomotic leakage after gastric surgery. World J Surg 2012;36:1617-1622. https://doi.org/10.1007/s00268-012-1559-3
  10. Sano T, Sasako M, Mizusawa J, Yamamoto S, Katai H, Yoshikawa T, et al. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma. Annals Surg [accepted 2016 May 3].
  11. Ebihara Y, Okushiba S, Kawarada Y, Kitashiro S, Katoh H. Outcome of functional end-to-end esophagojejunostomy in totally laparoscopic total gastrectomy. Langenbecks Arch Surg 2013;398:475-479. https://doi.org/10.1007/s00423-013-1051-z
  12. Haverkamp L, Weijs TJ, van der Sluis PC, van der Tweel I, Ruurda JP, van Hillegersberg R. Laparoscopic total gastrectomy versus open total gastrectomy for cancer: a systematic review and meta-analysis. Surg Endosc 2013;27:1509-1520. https://doi.org/10.1007/s00464-012-2661-1
  13. Lee MS, Lee JH, Park do J, Lee HJ, Kim HH, Yang HK. Comparison of short- and long-term outcomes of laparoscopicassisted total gastrectomy and open total gastrectomy in gastric cancer patients. Surg Endosc 2013;27:2598-2605. https://doi.org/10.1007/s00464-013-2796-8
  14. Wada N, Kurokawa Y, Takiguchi S, Takahashi T, Yamasaki M, Miyata H, et al. Feasibility of laparoscopy-assisted total gastrectomy in patients with clinical stage I gastric cancer. Gastric Cancer 2014;17:137-140. https://doi.org/10.1007/s10120-013-0235-0

Cited by

  1. Postoperative Complications of Laparoscopic Total Gastrectomy versus Open Total Gastrectomy for Gastric Cancer in a Meta-Analysis of High-Quality Case-Controlled Studies vol.2016, pp.None, 2016, https://doi.org/10.1155/2016/2617903
  2. Feasibility and diagnostic performance of dual-tracer-guided sentinel lymph node biopsy in cT1-2N0M0 gastric cancer: a systematic review and meta-analysis of diagnostic studies vol.15, pp.None, 2017, https://doi.org/10.1186/s12957-017-1159-7
  3. Long- and short-term outcomes of laparoscopic gastrectomy versus open gastrectomy in patients with clinically and pathological locally advanced gastric cancer: a propensity-score matching analysis vol.32, pp.2, 2016, https://doi.org/10.1007/s00464-017-5730-7
  4. Circular versus linear stapling in esophagojejunostomy after laparoscopic total gastrectomy for gastric cancer: a propensity score-matched study vol.403, pp.4, 2016, https://doi.org/10.1007/s00423-018-1678-x
  5. Single-arm confirmatory trial of laparoscopy-assisted total or proximal gastrectomy with nodal dissection for clinical stage I gastric cancer: Japan Clinical Oncology Group study JCOG1401 vol.22, pp.5, 2016, https://doi.org/10.1007/s10120-019-00929-9
  6. Comparative analysis of robotic gastrectomy and laparoscopic gastrectomy for gastric cancer in terms of their long-term oncological outcomes: a meta-analysis of 3410 gastric cancer patients vol.17, pp.None, 2016, https://doi.org/10.1186/s12957-019-1628-2
  7. Prognosis of proximal upper-third gastric cancer excluding tumors originating in the esophagogastric junction vol.15, pp.2, 2016, https://doi.org/10.14216/kjco.19017
  8. Obesity is a risk factor for internal hernia after laparoscopic or robot-assisted gastrectomy with mesenteric defect closure for gastric cancer vol.34, pp.1, 2016, https://doi.org/10.1007/s00464-019-06787-x
  9. Non-flap hand-sewn esophagogastrostomy as a simple anti-reflux procedure in laparoscopic proximal gastrectomy for gastric cancer vol.405, pp.4, 2016, https://doi.org/10.1007/s00423-020-01900-4
  10. Treatment of Gastric Cancer in Japan vol.88, pp.3, 2016, https://doi.org/10.1272/jnms.jnms.2021_88-315
  11. Analysis of Intestinal Flora and Levels of Epidermal Growth Factor Receptor, Interleukin-32, and Gastrin 17 in Patients with Gastric Cancer via Carbon Nanoparticle Laparoscopy vol.2021, pp.None, 2016, https://doi.org/10.1155/2021/6697597